{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:38:53Z","timestamp":1781264333542,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cpcardiol.2023.101751","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T20:24:32Z","timestamp":1682108672000},"page":"101751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cost-Effectiveness Analysis of Ibuprofen Versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates"],"prefix":"10.1016","volume":"48","author":[{"given":"Samaher","family":"Al-Shaibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Abushanab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Abounahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Awaisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-954X","authenticated-orcid":false,"given":"Daoud","family":"Al-Badriyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.cpcardiol.2023.101751_bib0001","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.105.592063","article-title":"Patent ductus arteriosus","volume":"114","author":"Schneider","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cpcardiol.2023.101751_bib0002","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","article-title":"The incidence of congenital heart disease","volume":"39","author":"Hoffman","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101751_bib0003","first-page":"138","article-title":"Patent ductus arteriosus: an overview","volume":"12","author":"Dice","year":"2007","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101751_bib0004","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1542\/peds.2005-1528","article-title":"Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less","volume":"117","author":"Koch","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101751_bib0005","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/11632870-000000000-00000","article-title":"Patent ductus arteriosus in premature neonates","volume":"72","author":"Mezu-Ndubuisi","year":"2012","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101751_bib0006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/14767050903198132","article-title":"Therapeutic closure of the ductus arteriosus: benefits and limitations","volume":"22","author":"Mercanti","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101751_bib0007","doi-asserted-by":"crossref","first-page":"e3975","DOI":"10.5812\/ijp.3975","article-title":"Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus","volume":"26","author":"Bagheri","year":"2016","journal-title":"Iran J Pediatr"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101751_bib0008","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/14767058.2011.607593","article-title":"Renal safety of non-steroidal anti-inflammatory drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus","volume":"24","author":"Fanos","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101751_bib0009","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/157488412803305830","article-title":"Pharmacological management of PDA: oral versus intravenous medications","volume":"7","author":"Demirel","year":"2012","journal-title":"Curr Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101751_bib0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00431-002-0915-y","article-title":"Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial","volume":"161","author":"Lago","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101751_bib0011","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1203\/00006450-200001000-00009","article-title":"Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus","volume":"47","author":"Patel","year":"2000","journal-title":"Pediatr Res"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.101751_bib0012","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1542\/peds.2011-0359","article-title":"Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment","volume":"128","author":"Hammerman","year":"2011","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.cpcardiol.2023.101751_bib0013","doi-asserted-by":"crossref","first-page":"e77888","DOI":"10.1371\/journal.pone.0077888","article-title":"Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial","volume":"8","author":"Dang","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101751_bib0014","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","article-title":"Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial","volume":"164","author":"Oncel","year":"2014","journal-title":"J Pediatr"},{"issue":"16","key":"10.1016\/j.cpcardiol.2023.101751_bib0015","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3109\/14767058.2013.871630","article-title":"Paracetamol effectiveness, safety and blood level monitoring during patent ductus arteriosus closure: a case series","volume":"27","author":"Kessel","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101751_bib0016","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000352068","article-title":"Is paracetamol a useful treatment for ibuprofen-resistant patent ductus arteriosus?","volume":"104","author":"Alan","year":"2013","journal-title":"Neonatology"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101751_bib0017","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/0300060517722698","article-title":"Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus","volume":"46","author":"Al-lawama","year":"2017","journal-title":"J Int Med Res"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.semperi.2018.05.007","article-title":"Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants","volume":"42","author":"Jasani","year":"2018","journal-title":"Semin Perinatol"},{"issue":"16","key":"10.1016\/j.cpcardiol.2023.101751_bib0019","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1080\/14767058.2017.1338263","article-title":"Paracetamol versus ibuprofen for the treatment of patent ductus arteriosus in preterm neonates: a meta-analysis of randomized controlled trials","volume":"31","author":"Huang","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101751_bib0020","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"1","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101751_bib0021","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/apc.APC_115_19","article-title":"Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial","volume":"13","author":"Soni","year":"2020","journal-title":"Ann Pediatr Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0022","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpeds.2020.01.058","article-title":"Oral paracetamol vs oral ibuprofen in patent ductus arteriosus: a randomized, controlled, noninferiority trial","volume":"222","author":"Kumar","year":"2020","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101751_bib0023","doi-asserted-by":"crossref","first-page":"F279","DOI":"10.1136\/archdischild-2011-300532","article-title":"Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants","volume":"97","author":"Erdeve","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101751_bib0024","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clinthera.2020.12.004","article-title":"Cost-effectiveness of oral versus intravenous ibuprofen therapy in preterm infants with patent ductus arteriosus in the neonatal intensive care setting: a cohort-based study","volume":"43","author":"Abushanab","year":"2021","journal-title":"Clin Ther"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14767050903198314","article-title":"Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns","volume":"22","author":"Guimaraes","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0026","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 19: adverse effects","author":"Peryer","year":"2020"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101751_bib0027","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.sjopt.2016.02.006","article-title":"Incidence of retinopathy of prematurity at two tertiary centers in Jeddah, Saudi Arabia","volume":"30","author":"Waheeb","year":"2016","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0028","first-page":"1","article-title":"Neonatal periventricular leukomalacia: current perspectives","volume":"8","author":"Ahya","year":"2018","journal-title":"Res Rep Neonatol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101751_bib0029","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.semperi.2013.01.006","article-title":"the role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia","volume":"37","author":"Clyman","year":"2013","journal-title":"Semin Perinatol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101751_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm","volume":"92","author":"Papile","year":"1978","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101751_bib0031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0031-3955(16)34975-6","article-title":"Necrotizing enterocolitis: treatment based on staging criteria","volume":"33","author":"Walsh","year":"1986","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101751_bib0032","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants","volume":"2","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101751_bib0033","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/cer-2020-0235","article-title":"Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: a systematic review of meta-analyses","volume":"10","author":"Al-Shaibi","year":"2021","journal-title":"J Comp Eff Res"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101751_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011271","article-title":"Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis","volume":"6","author":"Mitra","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0035","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2018.1447828","article-title":"On what basis are medical cost-effectiveness thresholds set? clashing opinions and an absence of data: a systematic review","volume":"11","author":"Cameron","year":"2018","journal-title":"Glob Health Action"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101751_bib0036","first-page":"291","article-title":"Oral versus intravenous medications for treatment of patent ductus arteriosus in preterm neonates: a cost-saving initiative","volume":"26","author":"Godin","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0037","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: Alternative approaches","volume":"93","author":"Marseille","year":"2014","journal-title":"Bull. of the World Health Organ"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0038","series-title":"GDP per capita, PPP (current international $) - Qatar. World Bank Open Data","year":"2022"},{"issue":"9","key":"10.1016\/j.cpcardiol.2023.101751_bib0039","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCULATIONAHA.105.594945","article-title":"Design of randomized controlled trials","volume":"115","author":"Stanley","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101751_bib0040","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.pctr.0010009","article-title":"Factors that can affect the external validity of randomized controlled trials","volume":"1","author":"Rothwell","year":"2006","journal-title":"PLoS Clin Trials"},{"issue":"12","key":"10.1016\/j.cpcardiol.2023.101751_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101387","article-title":"Cost-effectiveness analysis of out-of-hospital versus in-hospital extracorporeal cardiopulmonary resuscitation for out-hospital refractory cardiac arrest","volume":"47","author":"Al-Badriyeh","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0042","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2021.01.044","article-title":"Short- and long-term cost-effectiveness analysis of CYP2C19 genotype-guided therapy, universal clopidogrel, versus universal ticagrelor in post-percutaneous coronary intervention patients in Qatar","volume":"331","author":"AlMukdad","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101751_bib0043","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"12","author":"Jasani","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101751_bib0044","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/bcp.15291","article-title":"Comparative safety and efficacy of Paracetamol versus non-steroidal anti-inflammatory agents in neonates with patent ductus arteriosus: a systematic review and meta-analysis of Randomized Controlled Trials","volume":"88","author":"Katsaras","year":"2022","journal-title":"Br J Clin Pharmacol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623001688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623001688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:20:32Z","timestamp":1758939632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623001688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0146280623001688"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101751","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness Analysis of Ibuprofen Versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101751"}}